Mr. Gregory T. Lucier
Mr. Lucier most recently served as Chairman and Chief Executive Officer of NuVasive. Prior to this role, Mr. Lucier served as Chairman and Chief Executive Officer of Life Technologies—formerly Invitrogen—for eleven years. Mr. Lucier was heading Life Technologies during the acquisition by Thermo Fisher Scientific in 2013 for $15.6 billion —one of the largest Life Sciences acquisitions to date. Before that Mr. Lucier served as President, Medical Information Technologies, GE Healthcare, overseeing the networking of medical electronic devices, digital imaging and clinical information systems with revenues of almost $2 billion. He was promoted by the GE Board to an officer of General Electric Corporation to serve as Vice President Global Services, GE Healthcare, the company’s $2 billion healthcare services business. Mr. Lucier serves on several public and private company boards, including Catalent, Berkley Lights, Maravai LifeSciences, and Epic Sciences. He holds a Bachelor’s in Industrial Engineering from Pennsylvania State University and a Master’s in Business Administration from Harvard Business School.